Comparison of Safety and Efficacy ofMethadone vsMorphine for Treatment of Neonatal Abstinence Syndrome
暂无分享,去创建一个
B. Lester | N. Terrin | J. Breeze | D. Bogen | M. Hudak | E. Wachman | J. Shenberger | Erica L. Oliveira | K. D’Apolito | K. Harvey-Wilkes | P. Marro | Adam Czynski | B. Engelhardt
[1] L. Jansson,et al. The opioid-exposed newborn: assessment and pharmacologic management. , 2018, Journal of opioid management.
[2] C. Hollenbeak,et al. The economic burden of neonatal abstinence syndrome in the United States , 2017, Addiction.
[3] A. Beckwith,et al. Morphine Versus Methadone Treatment for Neonatal Withdrawal and Impact on Early Infant Development , 2017, Global pediatric health.
[4] D. Fegley,et al. Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients. , 2017, International journal of pharmaceutics.
[5] Inna Chervoneva,et al. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome , 2017, The New England journal of medicine.
[6] J. Davis,et al. Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant. , 2016, Seminars in perinatology.
[7] Jason R. Wiles,et al. Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study. , 2015, The Journal of pediatrics.
[8] Darrell Spurlock,et al. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome. , 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[9] J. Meinzen-Derr,et al. Cohort Analysis of a Pharmacokinetic-Modeled Methadone Weaning Optimization for Neonatal Abstinence Syndrome. , 2015, The Journal of pediatrics.
[10] J. Davis,et al. Opioids in pregnancy and neonatal abstinence syndrome. , 2015, Seminars in perinatology.
[11] W. Cooper,et al. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012 , 2015, Journal of Perinatology.
[12] Matthew M Davis,et al. Increasing Incidence and Geographic Distribution of Neonatal Abstinence Syndrome: United States 2009-2012 , 2015, Journal of Perinatology.
[13] S. Lorch,et al. Variation in treatment of neonatal abstinence syndrome in US Children's Hospitals, 2004–2011 , 2014, Journal of Perinatology.
[14] Marie J. Hayes,et al. Methadone versus morphine for treatment of neonatal abstinence syndrome: A prospective randomized clinical trial , 2014, Journal of Perinatology.
[15] Karen C DʼApolito,et al. Assessing Neonates for Neonatal Abstinence: Are You Reliable? , 2014, The Journal of perinatal & neonatal nursing.
[16] Steven Edward Kern,et al. The pharmacokinetics of methadone and its metabolites in neonates, infants, and children , 2014, Paediatric anaesthesia.
[17] P. Visintainer,et al. Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial , 2013, Journal of Perinatology.
[18] H. Jones,et al. Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes. , 2013, Drug and alcohol dependence.
[19] J. Mrozek,et al. Neonatal drug withdrawal. , 2013, Minnesota medicine.
[20] Amber M. Holbrook,et al. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. , 2012, Addiction.
[21] H. Jones,et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. , 2010, The New England journal of medicine.
[22] H. Jeffery,et al. Opiate treatment for opiate withdrawal in newborn infants. , 2010, The Cochrane database of systematic reviews.
[23] A. Bertolini,et al. Methadone--metabolism, pharmacokinetics and interactions. , 2004, Pharmacological research.